POZ - News : Rectal Microbicide Sees Positive Results in Trial
Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » News » February 2008

Web Exclusives

Evaluating the Costs of Earlier HIV Treatment

HIV Prevention Gets “Fergalicious”

Changing the HIV Treatment Paradigm

» More

Most Talked About

Magic Johnson Accused of Faking HIV (41)

The POZ/DDF Ratio (blog) (30)

Guidelines Prediction: Start Treatment Earlier (blog) (16)

HIV-Positive People Living Longer Than Ever Before (14)

Bone Marrow Transplant: Potential AIDS Cure? (8)

Obama Campaign Set to Boost Domestic HIV/AIDS Funding (8)

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Herpes Simplex Virus

Human Papilloma Virus (HPV)

Shingles

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

10 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

February 25, 2008

Rectal Microbicide Sees Positive Results in Trial

According to data unveiled at the 2008 Microbicide Conference in New Delhi today, the future finally looks bright for rectal microbicide gels as an effective way of preventing transmission of HIV and other sexually transmitted diseases, Aidsmap reports (Aidsmap.com, 2/25).

Preliminary data from the "U19" rectal microbicide program showed that the gel—which contains the non-nucleoside HIV drug UC-781—showed little signs of toxicity in human volunteers. According to Aidsmap, the U19 program also utilized an "in vivo–ex vivo" HIV infection model to monitor the efficacy of the gel in HIV prevention through application in cellular explants—small pieces of tissue kept alive in a nutrient medium—which were infected with two doses of the virus. The second dose contained 100 times more virus than the first.

After three weeks, explants grown from biopsies taken after gel application were shown to resist infection when exposed to the higher dose of HIV, suggesting that UC-781 may one day be utilized as a viable anal sex HIV prevention tool.


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

  comments 1 - 4 (of 4 total)    

Leon Anderson, Los Angeles, 2008-03-05 16:43:12
Tony! Regarding advocacy of no anal sex. Might as well expect bees not to make honey. Interesting article. Just wonder if "one" more possible seroconversion, down the line, is worth the risk.

Michael, New York, 2008-02-27 17:07:48
I hope this works. Condoms do, and yet so few men use them. Look at the frighteningly high infection rate lately. People who urge abstinence just don't understand human nature.

KEESHA BAILEY, SEATTLE, 2008-02-26 20:38:52
I THINK THAT IF THEY CAN CONTINUE TESTING THE SPERMICIDE AND IT DOES WORK THEN WHY NOT CONTINUE WITH THE PROJECT. GOOD LUCK.

tony, , 2008-02-26 14:11:22
why not advocate the stopping of the act of anal sex instead of making it easier for people to do so.

comments 1 - 4 (of 4 total)    


[Go to top]


Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Would legalizing prostitution reduce the spread of HIV?
Yes
No
I don't know.

Monthly Poll
Question: Do you believe that prisoners receive adequate health care?
Yes
No
I don't know.

Surveys
Tell us when and to whom you disclose your status.

Tell us about your travel experiences.

more surveys
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy